STEPHEN A SHERWIN Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for STEPHEN A SHERWIN.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of STEPHEN A SHERWIN. STEPHEN A SHERWIN is Chairman & C.E.O. in CELL GENESYS INC ($CEGE) and Chairman & Chief Exec. Officer in CELL GENESYS INC ($CEGE) and Chairman and CEO in CELL GENESYS INC ($CEGE) and Director in VICAL INC ($VICL) and Director in BIOGEN INC. ($IDPH) and Director in NEUROCRINE BIOSCIENCES INC ($NBIX) and Director in RIGEL PHARMACEUTICALS INC ($RIGL) and Director in ADURO BIOTECH, INC. ($ADRO) and Director in Verastem, Inc. ($VSTM) and Director in Neon Therapeutics, Inc. ($NTGN).
Latest Insider Trading Transactions of STEPHEN A SHERWIN
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, IDPH, VICL, CEGE, ADRO, NTGN, NBIX, RIGL, VSTM
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 05 2020 | IDPH | BIOGEN INC. | SHERWIN STEPHEN A | Director | Grant | A | 0.00 | 890 | 0 | 16,328 | 15.4 K to 16.3 K (+5.76 %) |
| May 28 2020 | ADRO | ADURO BIOTECH, INC ... | SHERWIN STEPHEN A | Director | Option Exercise | A | 3.00 | 30,000 | 90,000 | 30,000 | |
| May 21 2020 | NBIX | NEUROCRINE BIOSCIE ... | SHERWIN STEPHEN A | Director | Option Exercise | A | 119.93 | 6,018 | 721,739 | 6,018 | |
| May 06 2020 | NTGN | Neon Therapeutics, ... | SHERWIN STEPHEN A | Director | Option Exercise | D | 2.65 | 5,000 | 13,250 | 0 | |
| May 06 2020 | NTGN | Neon Therapeutics, ... | SHERWIN STEPHEN A | Director | Option Exercise | D | 4.64 | 18,500 | 85,840 | 0 | |
| May 06 2020 | NTGN | Neon Therapeutics, ... | SHERWIN STEPHEN A | Director | Option Exercise | D | 16.00 | 14,000 | 224,000 | 0 | |
| May 06 2020 | NTGN | Neon Therapeutics, ... | SHERWIN STEPHEN A | Director | Sell | D | 0.00 | 45,000 | 0 | 0 | 45 K to 0 (-100.00 %) |
| Apr 30 2020 | NBIX | NEUROCRINE BIOSCIE ... | SHERWIN STEPHEN A | Director | Sell | S | 99.39 | 17,687 | 1,757,966 | 29,861 | 47.5 K to 29.9 K (-37.20 %) |
| Mar 12 2020 | IDPH | BIOGEN INC. | SHERWIN STEPHEN A | Director | Option Exercise | M | 59.82 | 1,355 | 81,056 | 0 | |
| Mar 12 2020 | IDPH | BIOGEN INC. | SHERWIN STEPHEN A | Director | Option Exercise | M | 59.82 | 10,923 | 653,414 | 0 | |
| Mar 12 2020 | IDPH | BIOGEN INC. | SHERWIN STEPHEN A | Director | Sell | S | 295.29 | 270 | 79,728 | 15,438 | 15.7 K to 15.4 K (-1.72 %) |
| Mar 12 2020 | IDPH | BIOGEN INC. | SHERWIN STEPHEN A | Director | Buy | M | 58.46 | 1,355 | 79,213 | 15,708 | 14.4 K to 15.7 K (+9.44 %) |
| Mar 12 2020 | IDPH | BIOGEN INC. | SHERWIN STEPHEN A | Director | Sell | S | 295.22 | 2,164 | 638,845 | 14,353 | 16.5 K to 14.4 K (-13.10 %) |
| Mar 12 2020 | IDPH | BIOGEN INC. | SHERWIN STEPHEN A | Director | Buy | M | 58.46 | 10,923 | 638,559 | 16,517 | 5.6 K to 16.5 K (+195.26 %) |
| Jun 27 2019 | NTGN | Neon Therapeutics, ... | SHERWIN STEPHEN A | Director | Option Exercise | A | 4.64 | 18,500 | 85,840 | 18,500 | |
| Jun 20 2019 | IDPH | BIOGEN INC. | SHERWIN STEPHEN A | Director | Grant | A | 0.00 | 1,155 | 0 | 6,319 | 5.2 K to 6.3 K (+22.37 %) |
| May 23 2019 | NBIX | NEUROCRINE BIOSCIE ... | SHERWIN STEPHEN A | Director | Option Exercise | A | 79.79 | 10,000 | 797,900 | 10,000 | |
| May 15 2019 | ADRO | ADURO BIOTECH, INC ... | SHERWIN STEPHEN A | Director | Option Exercise | A | 3.29 | 30,000 | 98,700 | 30,000 | |
| Nov 05 2018 | IDPH | BIOGEN INC. | SHERWIN STEPHEN A | Director | Gift | G | 0.00 | 175 | 0 | 5,164 | 5.3 K to 5.2 K (-3.28 %) |
| Nov 05 2018 | IDPH | BIOGEN INC. | SHERWIN STEPHEN A | Director | Gift | G | 0.00 | 200 | 0 | 5,339 | 5.5 K to 5.3 K (-3.61 %) |
| Nov 05 2018 | IDPH | BIOGEN INC. | SHERWIN STEPHEN A | Director | Gift | G | 0.00 | 200 | 0 | 5,539 | 5.7 K to 5.5 K (-3.48 %) |
| Nov 05 2018 | IDPH | BIOGEN INC. | SHERWIN STEPHEN A | Director | Gift | G | 0.00 | 275 | 0 | 5,739 | 6 K to 5.7 K (-4.57 %) |
| Jun 14 2018 | IDPH | BIOGEN INC. | SHERWIN STEPHEN A | Director | Grant | A | 0.00 | 880 | 0 | 6,014 | 5.1 K to 6 K (+17.14 %) |
| Jun 13 2018 | NBIX | NEUROCRINE BIOSCIE ... | SHERWIN STEPHEN A | Director | Sell | S | 98.44 | 10,000 | 984,420 | 47,548 | 57.5 K to 47.5 K (-17.38 %) |
| Jun 08 2018 | ADRO | ADURO BIOTECH, INC ... | SHERWIN STEPHEN A | Director | Option Exercise | A | 6.60 | 20,000 | 132,000 | 20,000 | |
| May 25 2018 | NBIX | NEUROCRINE BIOSCIE ... | SHERWIN STEPHEN A | Director | Option Exercise | A | 94.64 | 12,500 | 1,183,000 | 12,500 | |
| May 25 2018 | NBIX | NEUROCRINE BIOSCIE ... | SHERWIN STEPHEN A | Director | Option Exercise | A | 94.64 | 12,500 | 1,183,000 | 12,500 | |
| Apr 30 2018 | NBIX | NEUROCRINE BIOSCIE ... | SHERWIN STEPHEN A | Director | Option Exercise | M | 7.05 | 15,000 | 105,750 | 0 | |
| Apr 30 2018 | NBIX | NEUROCRINE BIOSCIE ... | SHERWIN STEPHEN A | Director | Payment of Exercise | F | 79.44 | 1,331 | 105,735 | 57,548 | 58.9 K to 57.5 K (-2.26 %) |
| Apr 30 2018 | NBIX | NEUROCRINE BIOSCIE ... | SHERWIN STEPHEN A | Director | Buy | M | 7.05 | 15,000 | 105,750 | 58,879 | 43.9 K to 58.9 K (+34.18 %) |
| Dec 05 2017 | IDPH | BIOGEN INC. | SHERWIN STEPHEN A | Director | Gift | G | 0.00 | 400 | 0 | 5,134 | 5.5 K to 5.1 K (-7.23 %) |
| Dec 05 2017 | IDPH | BIOGEN INC. | SHERWIN STEPHEN A | Director | Gift | G | 0.00 | 200 | 0 | 5,534 | 5.7 K to 5.5 K (-3.49 %) |
| Dec 05 2017 | IDPH | BIOGEN INC. | SHERWIN STEPHEN A | Director | Gift | G | 0.00 | 250 | 0 | 5,734 | 6 K to 5.7 K (-4.18 %) |
| Jun 12 2017 | ADRO | ADURO BIOTECH, INC ... | SHERWIN STEPHEN A | Director | Option Exercise | A | 10.55 | 13,000 | 137,150 | 13,000 | |
| Jun 09 2017 | IDPH | BIOGEN INC. | SHERWIN STEPHEN A | Director | Grant | A | 0.00 | 1,055 | 0 | 5,984 | 4.9 K to 6 K (+21.40 %) |
| Jun 08 2017 | NBIX | NEUROCRINE BIOSCIE ... | SHERWIN STEPHEN A | Director | Option Exercise | A | 53.64 | 15,000 | 804,600 | 15,000 | |
| Feb 08 2017 | NBIX | NEUROCRINE BIOSCIE ... | SHERWIN STEPHEN A | Director | Option Exercise | M | 3.40 | 15,000 | 51,000 | 0 | |
| Feb 08 2017 | NBIX | NEUROCRINE BIOSCIE ... | SHERWIN STEPHEN A | Director | Payment of Exercise | F | 43.60 | 1,169 | 50,968 | 43,879 | 45 K to 43.9 K (-2.60 %) |
| Feb 08 2017 | NBIX | NEUROCRINE BIOSCIE ... | SHERWIN STEPHEN A | Director | Buy | M | 3.40 | 15,000 | 51,000 | 45,048 | 30 K to 45 K (+49.92 %) |
| Nov 14 2016 | IDPH | BIOGEN INC. | SHERWIN STEPHEN A | Director | Gift | G | 0.00 | 1,000 | 0 | 4,905 | 5.9 K to 4.9 K (-16.93 %) |
| Jun 10 2016 | ADRO | ADURO BIOTECH, INC ... | SHERWIN STEPHEN A | Director | Option Exercise | A | 12.42 | 13,000 | 161,460 | 13,000 | |
| Jun 09 2016 | IDPH | BIOGEN INC. | SHERWIN STEPHEN A | Director | Grant | A | 0.00 | 1,060 | 0 | 5,905 | 4.8 K to 5.9 K (+21.88 %) |
| May 24 2016 | NBIX | NEUROCRINE BIOSCIE ... | SHERWIN STEPHEN A | Director | Option Exercise | A | 47.89 | 15,000 | 718,350 | 15,000 | |
| May 12 2016 | RIGL | RIGEL PHARMACEUTIC ... | SHERWIN STEPHEN A | Director | Option Exercise | A | 2.40 | 40,000 | 96,000 | 40,000 | |
| Apr 18 2016 | NBIX | NEUROCRINE BIOSCIE ... | SHERWIN STEPHEN A | Director | Option Exercise | M | 3.07 | 15,000 | 46,050 | 0 | |
| Apr 18 2016 | NBIX | NEUROCRINE BIOSCIE ... | SHERWIN STEPHEN A | Director | Payment of Exercise | F | 46.86 | 982 | 46,017 | 30,048 | 31 K to 30 K (-3.16 %) |
| Apr 18 2016 | NBIX | NEUROCRINE BIOSCIE ... | SHERWIN STEPHEN A | Director | Buy | M | 3.07 | 15,000 | 46,050 | 31,030 | 16 K to 31 K (+93.57 %) |
| Jan 12 2016 | NBIX | NEUROCRINE BIOSCIE ... | SHERWIN STEPHEN A | Director | Option Exercise | M | 4.76 | 15,000 | 71,400 | 0 | |
| Jan 12 2016 | NBIX | NEUROCRINE BIOSCIE ... | SHERWIN STEPHEN A | Director | Payment of Exercise | F | 40.20 | 1,776 | 71,395 | 16,030 | 17.8 K to 16 K (-9.97 %) |
| Jan 12 2016 | NBIX | NEUROCRINE BIOSCIE ... | SHERWIN STEPHEN A | Director | Buy | M | 4.76 | 15,000 | 71,400 | 17,806 | 2.8 K to 17.8 K (+534.57 %) |
| Jun 26 2015 | ADRO | ADURO BIOTECH, INC ... | SHERWIN STEPHEN A | Director | Option Exercise | A | 33.80 | 15,000 | 507,000 | 15,000 | |
| Jun 16 2015 | VSTM | Verastem, Inc. | SHERWIN STEPHEN A | Director | Option Exercise | A | 7.99 | 17,969 | 143,572 | 17,969 | |
| Jun 11 2015 | IDPH | BIOGEN INC. | SHERWIN STEPHEN A | Director | Grant | A | 0.00 | 695 | 0 | 4,845 | 4.2 K to 4.8 K (+16.75 %) |
| Jun 01 2015 | NBIX | NEUROCRINE BIOSCIE ... | SHERWIN STEPHEN A | Director | Option Exercise | A | 42.76 | 25,000 | 1,069,000 | 25,000 | |
| May 26 2015 | VICL | VICAL INC | SHERWIN STEPHEN A | Director | Option Exercise | A | 0.89 | 50,000 | 44,500 | 50,000 | |
| May 26 2015 | VICL | VICAL INC | SHERWIN STEPHEN A | Director | Grant | A | 0.01 | 7,500 | 75 | 22,003 | 14.5 K to 22 K (+51.71 %) |
| May 14 2015 | RIGL | RIGEL PHARMACEUTIC ... | SHERWIN STEPHEN A | Director | Option Exercise | A | 3.96 | 40,000 | 158,400 | 40,000 | |
| Mar 11 2015 | IDPH | BIOGEN INC. | SHERWIN STEPHEN A | Director | Option Exercise | M | 59.82 | 6,000 | 358,920 | 10,675 | |
| Mar 11 2015 | IDPH | BIOGEN INC. | SHERWIN STEPHEN A | Director | Sell | S | 409.67 | 6,000 | 2,458,020 | 4,150 | 10.2 K to 4.2 K (-59.11 %) |
| Mar 11 2015 | IDPH | BIOGEN INC. | SHERWIN STEPHEN A | Director | Buy | M | 59.82 | 6,000 | 358,920 | 10,150 | 4.2 K to 10.2 K (+144.58 %) |
| Mar 11 2015 | IDPH | BIOGEN INC. | SHERWIN STEPHEN A | Director | Gift | G | 0.00 | 275 | 0 | 4,150 | 4.4 K to 4.2 K (-6.21 %) |
| Oct 15 2009 | CEGE | CELL GENESYS INC | SHERWIN STEPHEN A | Chairman and CEO | Option Exercise | D | 9.50 | 70,000 | 665,000 | 0 | |
| Oct 15 2009 | CEGE | CELL GENESYS INC | SHERWIN STEPHEN A | Chairman and CEO | Option Exercise | D | 19.63 | 80,000 | 1,570,400 | 0 | |
| Oct 15 2009 | CEGE | CELL GENESYS INC | SHERWIN STEPHEN A | Chairman and CEO | Option Exercise | D | 15.42 | 100,000 | 1,542,000 | 0 | |
| Oct 15 2009 | CEGE | CELL GENESYS INC | SHERWIN STEPHEN A | Chairman and CEO | Option Exercise | D | 9.14 | 60,000 | 548,400 | 0 | |
| Oct 15 2009 | CEGE | CELL GENESYS INC | SHERWIN STEPHEN A | Chairman and CEO | Option Exercise | D | 14.04 | 60,000 | 842,400 | 0 | |
| Oct 15 2009 | CEGE | CELL GENESYS INC | SHERWIN STEPHEN A | Chairman and CEO | Option Exercise | D | 6.73 | 12,252 | 82,456 | 0 | |
| Oct 15 2009 | CEGE | CELL GENESYS INC | SHERWIN STEPHEN A | Chairman and CEO | Option Exercise | D | 6.73 | 100,248 | 674,669 | 0 | |
| Oct 15 2009 | CEGE | CELL GENESYS INC | SHERWIN STEPHEN A | Chairman and CEO | Option Exercise | D | 6.07 | 41,367 | 251,098 | 0 | |
| Oct 15 2009 | CEGE | CELL GENESYS INC | SHERWIN STEPHEN A | Chairman and CEO | Option Exercise | D | 6.07 | 18,633 | 113,102 | 0 | |
| Oct 15 2009 | CEGE | CELL GENESYS INC | SHERWIN STEPHEN A | Chairman and CEO | Option Exercise | D | 3.07 | 72,239 | 221,774 | 0 | |
| Oct 15 2009 | CEGE | CELL GENESYS INC | SHERWIN STEPHEN A | Chairman and CEO | Option Exercise | D | 3.07 | 27,761 | 85,226 | 0 | |
| Oct 15 2009 | CEGE | CELL GENESYS INC | SHERWIN STEPHEN A | Chairman and CEO | Option Exercise | D | 1.84 | 319,740 | 588,322 | 0 | |
| Oct 15 2009 | CEGE | CELL GENESYS INC | SHERWIN STEPHEN A | Chairman and CEO | Option Exercise | D | 1.84 | 55,260 | 101,678 | 0 | |
| Oct 15 2009 | CEGE | CELL GENESYS INC | SHERWIN STEPHEN A | Chairman and CEO | Sell | D | 0.00 | 474,621 | 0 | 0 | 474.6 K to 0 (-100.00 %) |
| Jun 08 2005 | CEGE | CELL GENESYS INC | SHERWIN STEPHEN A | Chairman & C.E.O. | Buy | P | 4.96 | 2,000 | 9,920 | 419,466 | 417.5 K to 419.5 K (+0.48 %) |
| Jun 08 2005 | CEGE | CELL GENESYS INC | SHERWIN STEPHEN A | Chairman & C.E.O. | Buy | P | 4.95 | 500 | 2,475 | 417,466 | 417 K to 417.5 K (+0.12 %) |
| Mar 14 2005 | CEGE | CELL GENESYS INC | SHERWIN STEPHEN A | Chairman & C.E.O. | Option Exercise | M | 4.13 | 3,940 | 16,253 | 7,777 | |
| Mar 14 2005 | CEGE | CELL GENESYS INC | SHERWIN STEPHEN A | Chairman & C.E.O. | Option Exercise | M | 4.13 | 6,060 | 24,998 | 0 | |
| Mar 14 2005 | CEGE | CELL GENESYS INC | SHERWIN STEPHEN A | Chairman & C.E.O. | Buy | M | 4.13 | 3,940 | 16,253 | 416,966 | 413 K to 417 K (+0.95 %) |
| Mar 14 2005 | CEGE | CELL GENESYS INC | SHERWIN STEPHEN A | Chairman & C.E.O. | Buy | M | 4.13 | 6,060 | 24,998 | 413,026 | 407 K to 413 K (+1.49 %) |
| Feb 04 2005 | CEGE | CELL GENESYS INC | SHERWIN STEPHEN A | Chairman and CEO | Option Exercise | A | 6.73 | 112,500 | 757,125 | 112,500 | |
| Sep 14 2004 | CEGE | CELL GENESYS INC | SHERWIN STEPHEN A | Chairman & C.E.O. | Gift | G | 9.51 | 3,000 | 28,530 | 30,000 | 27 K to 30 K (+11.11 %) |
| Sep 14 2004 | CEGE | CELL GENESYS INC | SHERWIN STEPHEN A | Chairman & C.E.O. | Gift | G | 9.51 | 10,000 | 95,100 | 405,222 | 395.2 K to 405.2 K (+2.53 %) |
| Sep 14 2004 | CEGE | CELL GENESYS INC | SHERWIN STEPHEN A | Chairman & C.E.O. | Buy | J | 6.13 | 1,668 | 10,222 | 0 | -1,668 to 0 (-100.00 %) |
| Sep 14 2004 | CEGE | CELL GENESYS INC | SHERWIN STEPHEN A | Chairman & C.E.O. | Buy | J | 9.51 | 600 | 5,706 | 0 | -600 to 0 (-100.00 %) |
| Feb 03 2004 | CEGE | CELL GENESYS INC | SHERWIN STEPHEN A | Chairman & C.E.O. | Option Exercise | A | 14.04 | 60,000 | 842,400 | 980,000 | |
| Oct 06 2003 | CEGE | CELL GENESYS INC | SHERWIN STEPHEN A | Chairman & C.E.O. | Gift | G | 0.00 | 2,000 | 0 | 30,000 | 32 K to 30 K (-6.25 %) |
| Oct 06 2003 | CEGE | CELL GENESYS INC | SHERWIN STEPHEN A | Chairman & C.E.O. | Gift | G | 0.00 | 5,000 | 0 | 415,954 | 421 K to 416 K (-1.19 %) |
| Aug 04 2003 | CEGE | CELL GENESYS INC | SHERWIN STEPHEN A | Chairman & Chief Ex ... | Gift | G | 0.00 | 10,000 | 0 | 422,954 | 433 K to 423 K (-2.31 %) |
| Aug 04 2003 | CEGE | CELL GENESYS INC | SHERWIN STEPHEN A | Chairman & Chief Ex ... | Gift | G | 0.00 | 10,000 | 0 | 422,954 | 433 K to 423 K (-2.31 %) |
| Aug 04 2003 | CEGE | CELL GENESYS INC | SHERWIN STEPHEN A | Chairman & Chief Ex ... | Buy | J | 8.08 | 604 | 4,882 | 432,954 | 432.4 K to 433 K (+0.14 %) |
Page: 1